This activity is targeted to any clinician with interest in education on migraine, including primary care physicians, nurse practitioners, physician assistants, emergency room physicians, and pediatricians.
This enduring material will be available for two years, beginning September 16, 2021 through September 16, 2023.
After participating in this educational activity, participants should be better able to:
Module 3: ABCs of Acute Therapy in Primary Care
METHOD OF PARTICIPATION
To receive credit for this activity, the participant must read the CME information (including learning objectives and disclosures) and participate in the entire activity (all 4 modules). Upon finishing the activity, the participant will need to complete the session post-test, evaluation, and all required personal information. To receive CME certificate, participant will need to pass the post-test with 75% accuracy or better. If participant receives less than 75%, participant should review the activity and take the test again. After successful completion of the activity, participant will receive a framed copy of their CME certificate in the mail within 10-14 days, as well as an emailed copy of their certificate to submit to their appropriate licensing boards.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Primary Care Network (PCN) and the National Headache Foundation. Primary Care Network is accredited by the ACCME to provide continuing medical education for physicians.
Primary Care Network designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA accepts certificates of participation for educational activities certified for Category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 2 hours of Category 1 credit for completing this program.
The American Academy of Nurse Practitioners Certification Board (AANPCB) and American Nurses Credentialing Center (ANCC) accept AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
Other Healthcare Professionals
All other healthcare professionals will receive a certificate of participation.
UNLABELED USE DECLARATION
During their presentation, faculty may discuss unlabeled or investigational use which is not approved for a commercial product. Faculty members are required to disclose this information to the audience when referring to an unlabeled or investigational use.
The opinions, ideas, recommendations, and perspectives expressed during this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Primary Care Network, advisory boards and consultants, or the activity's commercial supporters.
ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
This activity is supported by educational grants provided by Amgen, Biohaven Pharmaceuticals, and Lilly.
FACULTY/PLANNING COMMITTEE DISCLOSURES
All relevant financial relationships have been mitigated for this activity.
Vincent Martin, MD – Faculty/Content Developer – Module 1
President, National Headache Foundation
Director, Headache and Facial Pain Center
University of Cincinnati College of Medicine
Advisory Board: Lundbeck
Consultant: Abbvie, Amgen, Lilly, Biohaven, Theranica
Research Grants: Abbvie, Amgen, Lilly, TEVA
Speaker’s Bureau: Amgen, Lilly, Biohaven, TEVA
Merle Diamond, MD[JH3] – Faculty/Content Developer – Module 2
Director, Diamond Headache Clinic
Advisory Board/Consultant: Allergan/Abbvie, Amgen, Axsome, Biohaven, Impel NeuroPharma, Lilly, Lundbeck, TEVA
Research Grants: Allergan/Abbvie, Amgen, Lilly, Lundbeck, TEVA
Speaker’s Bureau: Allergan/Abbvie, Amgen, Axsome, Biohaven, Lilly, Lundbeck, TEVA
Jan Lewis Brandes, MD – Faculty/Content Developer – Module 3
Director & Founder, Nashville Neuroscience Group
Assistant Professor, Neurology
Advisory Board: Amgen, Lilly, TEVA, Lundbeck, Impel, Theranica
Consultant: Amgen, Lilly, Lundbeck, Impel, TEVA
Research Grants: Amgen, Lilly, Allergan, TEVA, Biohaven
Speaker’s Bureau: Lilly, Amgen, TEVA, Lundbeck, Allergan
Paul G. Mathew, MD – Faculty/Content Developer – Module 4
Assistant Professor of Neurology
Harvard Medical School
Board Certified Headache Specialist
Advisory Board & Consultant: Allergan, Amgen, Biohaven, Lilly, Revance
The following individuals have no relevant financial relationships:
Brian Koffman, MD – Reviewer
Chief Medical Officer, CLL Society
Jill Hays, CHCP – Planner
Executive Director, Primary Care Network
Cindy Fisher – Planner
CME Program Manager, Primary Care Network
This activity is accredited by Primary Care Network.